[What information about risks of neuroleptics should be given during pregnancy?].
Jerling
M
M
Avdelningen för klinisk farmakologi, Huddinge sjukhus.
D014150:Antipsychotic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008431:Maternal-Fetal Exchange / Q000187:drug effects; D010353:Patient Education as Topic; D011247:Pregnancy; D012307:Risk Factors
D014150:Antipsychotic Agents
Vilken information skall ges om neuroleptikarisker under graviditet?